Abiopharma

🔍 LE DUY LOAN T (Director)

Company: CIRRUS LOGIC, INC. (CRUS)

Report Date: 2026-07-29

Detailed Transactions and Holdings:

• Acquired 1,998 shares of Common Stock (Direct)
  Date: 2026-07-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 6,197.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,998 shares of Restricted Stock Units (Derivative)
  Date: 2026-07-29 | Code: M | Exercise: 2026-07-29 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 1,623 shares of Restricted Stock Units (Derivative)
  Date: 2026-07-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,623.00 | transaction_form_type: 4 | Footnotes: F3, F4, F5, F5

Footnotes:

• F1: Each restricted stock unit was the economic equivalent of one share of common stock. The restricted stock unit vested on July 29, 2026.
• F2: Expiration Date of July 29, 2026.
• F3: Each restricted stock unit represents a contingent right to receive one share of Cirrus Logic common stock.
• F4: Restricted Stock Units granted upon re-election to Cirrus Logic, Inc.'s Board of Directors.
• F5: 100% of the restricted stock units will vest on the earlier of: (a) the date of the Company's next Annual Meeting or (b) on July 31, 2027, the 1-year anniversary of the grant date.